Neurology Minute

Episod

• 
  Resolution of PML after Treatment with Virus-Specific T Cells and HCT 25.09.2026 3min

  Dr. Justin Abbatemarco and Dr. Irene Cortese discuss recent advances in the treatment of progressive multifocal leukoencephalopathy (PML), focusing on immune-based therapies like virus-specific T cells and immune checkpoint inhibitors.  Show citation:  Gonzalez CE, Fletcher A, Jenkins TL, et al. Resolution of PML after Treatment with Virus-Specific T Cells and HCT. N Engl J Med. 2026;394(20):2061-2064. doi:10.1056/NEJMc2514186 
• 
  Primary Motor Cortex Involvement and Seizure Risk in Patients With Brain Metastases 24.09.2026 4min

  Dr. Kait Nevel and Drs. Ayal Aizer and Clara Baselga-Garriga discuss the link between primary motor cortex involvement in brain metastases and increased seizure risk. Show citation:  Baselga-Garriga C, Purohit S, Lamba N, et al. Primary Motor Cortex Involvement and Its Association With Seizure Risk in Patients With Brain Metastases. Neurology. 2026;106(7):e214714. doi:10.1212/WNL.0000000000214714
• 
  Delusional Misidentification Syndromes - Part 2 23.09.2026 3min

  In part two of this nine-part series, Dr. Christine Cliatt-Brown discusses Capgras syndrome. 
• 
  Delusional Misidentification Syndromes - Part 1 22.09.2026 3min

  In part one of this nine-part series, Dr. Christine Cliatt-Brown provides an overview of delusional misidentification syndromes. 
• 
  Updates in Neuroinfectious Disease - Part 7 21.09.2026 6min

  In the final episode of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss the complex role of TNF alpha inhibition in tuberculosis treatment and the use of infliximab and other targeted therapies to manage inflammation. 
• 
  September 7, 2026 Capitol Hill Report: BrainPAC 16.09.2026 2min

  In this episode, Dr. Jose Posas reviews the Capitol Hill Report from September 7th, discussing the busy month ahead for Congress, BrainPAC, and a couple of other advocacy news items.  Stay updated with what's happening on the hill by visiting aan.com/chr.  Learn how you can get involved with AAN advocacy. 
• 
  Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments - Part 2 15.09.2026 1min

  In part two of this series, Dr. Aaron Zelikovich and Dr. Bhaskar Roy discuss recommendations to help neurologists navigate the expanding landscape of myasthenia gravis treatments.  Show citation:  McLaren NP, Rosati M, Zhong W, et al. Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments: A Bayesian Network Meta-Analysis. Neurology. 2026;107(3):e218351. doi:10.1212/WNL.0000000000218351  
• 
  Bridging the Artificial Intelligence Training Gap - Part 2 14.09.2026 3min

  In the second episode of this series, Dr. Justin Abbatemarco and Dr. Sara Marceglia discuss the risks of incorporating AI into clinical practice.  Show citation:  Vozzi C, Sibilla M, Sandri D, et al. Education Research: Bridging the Artificial Intelligence Training Gap: Evidence from a National Survey of Italian Neurology Residents. Neurol Educ. 2026;5(1):e200289. Published 2026 Jan 27. doi:10.1212/NE9.0000000000200289  
• 
  Updates in Neuroinfectious Disease - Part 6 11.09.2026 6min

  In the sixth episode of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss high-dose rifampin in TB meningitis. 
• 
  Bridging the Artificial Intelligence Training Gap - Part 1 10.09.2026 2min

  In part one of this series, Dr. Justin Abbatemarco and Dr. Alberto Priori discussed the use of artificial intelligence in neurology among peers, not just trainees.  Show citation:  Vozzi C, Sibilla M, Sandri D, et al. Education Research: Bridging the Artificial Intelligence Training Gap: Evidence from a National Survey of Italian Neurology Residents. Neurol Educ. 2026;5(1):e200289. Published 2026 Jan 27. doi:10.1212/NE9.0000000000200289  
• 
  September 2026 President Spotlight: Our Next Step in Brain Health 09.09.2026 3min

  In the September episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost discuss BrainHealth.com and the AAN's expanding brain health movement.  Stay informed by watching the President's Spotlight video.  
• 
  Updates in Neuroinfectious Disease - Part 5 08.09.2026 4min

  In the fifth episode of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss dexamethasone and listeria meningitis. 
• 
  Updates in Neuroinfectious Disease - Part 4 07.09.2026 5min

  In the fourth episode of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss the use of dexamethasone in the treatment of pneumococcal meningitis.
• 
  Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments - Part 1 04.09.2026 1min

  In the first installment of this series, Dr. Aaron Zelikovich and Dr. Bhaskar Roy discuss how emerging treatments for myasthenia gravis compare to one another.  Show citation:  McLaren NP, Rosati M, Zhong W, et al. Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments: A Bayesian Network Meta-Analysis. Neurology. 2026;107(3):e218351. doi:10.1212/WNL.0000000000218351  
• 
  National Trends in Medicare Charges and Reimbursement for Inpatient Neurologic Care 03.09.2026 2min

  Dr. Jason Crowell and Ka-Ho Wong discuss national trends in Medicare reimbursement for inpatient neurologic care.  Show citation:  Wong KH, Castillo M, King J, et al. National Trends in Medicare Charges and Reimbursement for Inpatient Neurologic Care, 2013-2023. Neurology. 2026;107(6):e218460. doi:10.1212/WNL.0000000000218460 
• 
  Updates in Neuroinfectious Disease - Part 3 02.09.2026 5min

  In the third episode of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss HSV encephalitis and dexamethasone. 
• 
  Updates in Neuroinfectious Disease - Part 2 01.09.2026 5min

  In part two of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss pegivirus-associated encephalomyelitis. 
• 
  Updates in Neuroinfectious Disease - Part 1 31.08.2026 4min

  In part one of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss acute necrotizing encephalopathy.
• 
  2026 Alzheimer's Association International Conference - Part 1 27.08.2026 1min

  In part one of this series, Drs. Greg Cooper, Trey Bateman, and Gregg Day discussed key takeaways from the 2026 Alzheimer's Association International Conference, focusing on blood-based biomarkers, anti-amyloid therapies, and other important highlights.      
• 
  Recap from the 2026 AAN Autoimmune Neurology Conference 26.08.2026 2min

  Dr. Justin Abbatemarco recaps a presentation on Hashimoto encephalopathy from the AAN Autoimmune Neurology Conference.   Show citation:    Valencia-Sanchez C, Pittock SJ, Mead-Harvey C, et al. Brain dysfunction and thyroid antibodies: autoimmune diagnosis and misdiagnosis. Brain Commun. 2021;3(2):fcaa233. Published 2021 Jan 5. doi:10.1093/braincomms/fcaa233    Brain, Jellinek E, Ball K HASHIMOTO'S DISEASE AND ENCEPHALOPATHY The Lancet, 288, 512-514    Mattozzi S, Sabater L, Escudero D, et al. Hashimoto encephalopathy in the 21st century. Neurology. 2020;94(2):e217-e224. doi:10.1212/WNL.0000000000008785